SHA:600668

2 stories mentioning SHA:600668Updated 26d ago

Every FINWIRES story that references SHA:600668, newest first.

Zhejiang Jianfeng Gets Registration Certificates for Two Drugs

Zhejiang Jianfeng (SHA:600668) received drug registration certificates from China's National Medical Products Administration for two drugs, according to a Shanghai bourse filing on Friday.The certificates are for vonoprazan fumarate tablets, which is used to treat gastric ulcer, duodenal ulcer and reflux esophagitis, and azilsartan potassium tablets, which lowers blood pressure.

SHA:600668

Asia64d ago

Zhejiang Jianfeng Gets Regulatory Nod for Combination Diabetes Drug

Zhejiang Jianfeng Group (SHA:600668) unit Jianfeng Pharmaceutical obtained marketing and manufacturing approval from China's drug regulator for metformin and empagliflozin tablets.The combination therapy is used for type 2 diabetes, according to a Tuesday filing with the Shanghai bourse.The registration is valid for 24 months.Shares of the pharmaceutical company closed 2% lower Tuesday.

SHA:600668

Track with the FINWIRES app suite

FolioX

Track SHA:600668 in your portfolio

WheelAI

Analyze SHA:600668 options with the wheel strategy

StockInsider

See market sentiment on SHA:600668